Loading clinical trials...
Loading clinical trials...
Phase I Trial of AVD Plus Lenalidomide (Revlimid) in Elderly Intermediate or Advanced Stage Hodgkin Lymphoma Patients
Conditions
Interventions
Doxorubicine
DTIC
+2 more
Locations
1
Germany
1st Dept. of Medicine, Cologne University Hospital
Cologne, North Rhine-Westphalia, Germany
Start Date
April 1, 2010
Primary Completion Date
April 1, 2014
Completion Date
February 1, 2016
Last Updated
March 22, 2018
NCT05529069
NCT06189391
NCT05006716
NCT06026319
NCT05442515
NCT06745076
Lead Sponsor
University of Cologne
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions